1. Home
2. 2025 ICD-10 PCS Index
3. X

2025 ICD-10 PCS INDEX TERMS STARTING WITH X

• Destruction Renal Sympathetic Nerve(s) to New Technology Group 9 with Ultrasound Ablation, Percutaneous Approach - X051329
• Destruction Renal Sympathetic Nerve(s) to New Technology Group 10 with Radiofrequency Ablation, Percutaneous Approach - X05133A
• Insertion Sphenopalatine Ganglion to New Technology Group 8 with Neurostimulator Lead, Percutaneous Approach - X0HK3Q8
• Insertion Vagus Nerve to New Technology Group 8 with Neurostimulator Lead with Paired Stimulation System, Percutaneous Approach - X0HQ3R8
• Other Procedures Prefrontal Cortex to New Technology Group 8 with Computer-assisted Transcranial Magnetic Stimulation, External Approach - X0Z0X18
• Dilation Anterior Tibial Artery, Right to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach - X27P3TA
• Dilation Anterior Tibial Artery, Left to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach - X27Q3TA
• Dilation Posterior Tibial Artery, Right to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach - X27R3TA
• Dilation Posterior Tibial Artery, Left to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach - X27S3TA
• Dilation Peroneal Artery, Right to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach - X27T3TA
• Dilation Peroneal Artery, Left to New Technology Group 10 with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach - X27U3TA
• Division Aortic Valve to New Technology Group 10 with Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach - X28F3VA
• Assistance Innominate Artery and Left Common Carotid Artery to New Technology Group 2 with Cerebral Embolic Filtration, Dual Filter, Percutaneous Approach - X2A5312
• Assistance Aortic Arch to New Technology Group 5 with Cerebral Embolic Filtration, Single Deflection Filter, Percutaneous Approach - X2A6325
• Assistance Coronary Sinus to New Technology Group 8 with Intermittent Coronary Sinus Occlusion, Percutaneous Approach - X2A7358
• Assistance Common Carotid Artery, Right to New Technology Group 6 with Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit, Percutaneous Approach - X2AH336
• Assistance Common Carotid Artery, Left to New Technology Group 6 with Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit, Percutaneous Approach - X2AJ336
• Extirpation Abdominal Aorta to New Technology Group 7 with Computer-aided Mechanical Aspiration, Percutaneous Approach - X2CP3T7
• Extirpation Upper Extremity Vein, Right to New Technology Group 7 with Computer-aided Mechanical Aspiration, Percutaneous Approach - X2CQ3T7
• Extirpation Upper Extremity Vein, Left to New Technology Group 7 with Computer-aided Mechanical Aspiration, Percutaneous Approach - X2CR3T7
• Extirpation Lower Extremity Artery, Right to New Technology Group 7 with Computer-aided Mechanical Aspiration, Percutaneous Approach - X2CS3T7
• Extirpation Lower Extremity Artery, Left to New Technology Group 7 with Computer-aided Mechanical Aspiration, Percutaneous Approach - X2CT3T7
• Extirpation Lower Extremity Vein, Right to New Technology Group 7 with Computer-aided Mechanical Aspiration, Percutaneous Approach - X2CU3T7
• Extirpation Lower Extremity Vein, Left to New Technology Group 7 with Computer-aided Mechanical Aspiration, Percutaneous Approach - X2CV3T7
• Extirpation Great Vessel to New Technology Group 7 with Computer-aided Mechanical Aspiration, Percutaneous Approach - X2CY3T7
• Insertion Inferior Vena Cava to New Technology Group 9 with Intraluminal Device, Bioprosthetic Valve, Percutaneous Approach - X2H03R9
• Insertion Superior Vena Cava to New Technology Group 9 with Intraluminal Device, Bioprosthetic Valve, Percutaneous Approach - X2H13R9
• Insertion Femoral Vein, Right to New Technology Group 9 with Intraluminal Device, Bioprosthetic Valve, Open Approach - X2H20R9
• Insertion Femoral Vein, Left to New Technology Group 9 with Intraluminal Device, Bioprosthetic Valve, Open Approach - X2H30R9
• Insertion Atrium, Right to New Technology Group 9 with Intracardiac Pacemaker, Dual-Chamber, Percutaneous Approach - X2H63V9
• Insertion Ventricle, Right to New Technology Group 9 with Intracardiac Pacemaker, Dual-Chamber, Percutaneous Approach - X2HK3V9
• Insertion Axillary Artery, Right to New Technology Group 9 with Conduit to Short-term External Heart Assist System, Open Approach - X2HL0F9
• Insertion Axillary Artery, Left to New Technology Group 9 with Conduit to Short-term External Heart Assist System, Open Approach - X2HM0F9
• Insertion Thoracic Aorta, Ascending to New Technology Group 9 with Conduit to Short-term External Heart Assist System, Open Approach - X2HX0F9
• Inspection Heart to New Technology Group 7 with Transthoracic Echocardiography, Computer-aided Guidance, External Approach - X2JAX47
• Bypass Radial Artery, Right to New Technology Group 7 with Thermal Resistance Energy, Percutaneous Approach - X2KB317
• Bypass Radial Artery, Left to New Technology Group 7 with Thermal Resistance Energy, Percutaneous Approach - X2KC317
• Bypass Femoral Artery, Right to New Technology Group 9 with Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach - X2KH3D9
• Bypass Femoral Artery, Right to New Technology Group 9 with Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach - X2KH3E9
• Bypass Femoral Artery, Left to New Technology Group 9 with Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach - X2KJ3D9
• Bypass Femoral Artery, Left to New Technology Group 9 with Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach - X2KJ3E9
• Replacement Upper Extremity Artery, Right to New Technology Group 10 with Bioengineered Human Acellular Vessel, Open Approach - X2R50WA
• Replacement Upper Extremity Artery, Left to New Technology Group 10 with Bioengineered Human Acellular Vessel, Open Approach - X2R60WA
• Replacement Lower Extremity Artery, Right to New Technology Group 10 with Bioengineered Human Acellular Vessel, Open Approach - X2R70WA
• Replacement Lower Extremity Artery, Left to New Technology Group 10 with Bioengineered Human Acellular Vessel, Open Approach - X2R80WA
• Replacement Tricuspid Valve to New Technology Group 10 with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach - X2RJ3RA
• Replacement Thoracic Aorta, Arch to New Technology Group 7 with Branched Synthetic Substitute with Intraluminal Device, Open Approach - X2RX0N7
• Supplement Coronary Artery/Arteries to New Technology Group 9 with Vein Graft Extraluminal Support Device(s), Open Approach - X2U4079
• Supplement Upper Extremity Vein, Right to New Technology Group 9 with Synthetic Substitute, Extraluminal Support Device, Open Approach - X2UQ0P9
• Supplement Upper Extremity Vein, Left to New Technology Group 9 with Synthetic Substitute, Extraluminal Support Device, Open Approach - X2UR0P9
• Restriction Coronary Sinus to New Technology Group 7 with Reduction Device, Percutaneous Approach - X2V73Q7
• Restriction Descending Thoracic Aorta and Abdominal Aorta to New Technology Group 10 with Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries, Percutaneous Approach - X2VE3SA
• Restriction Thoracic Aorta, Descending to New Technology Group 7 with Branched Synthetic Substitute with Intraluminal Device, Open Approach - X2VW0N7
• Monitoring Upper GI to New Technology Group 7 with Oxygen Saturation, Percutaneous Endoscopic Approach - XD2G4V7
• Monitoring Upper GI to New Technology Group 7 with Oxygen Saturation, Via Natural or Artificial Opening Endoscopic Approach - XD2G8V7
• Monitoring Lower GI to New Technology Group 7 with Oxygen Saturation, Percutaneous Endoscopic Approach - XD2H4V7
• Monitoring Lower GI to New Technology Group 7 with Oxygen Saturation, Via Natural or Artificial Opening Endoscopic Approach - XD2H8V7
• Irrigation Lower GI to New Technology Group 7 with Intraoperative Single-use Oversleeve, Via Natural or Artificial Opening Endoscopic Approach - XDPH8K7
• Destruction Liver to New Technology Group 8 with Ultrasound-guided Cavitation, External Approach - XF50X08
• Destruction Liver, Right Lobe to New Technology Group 8 with Ultrasound-guided Cavitation, External Approach - XF51X08
• Destruction Liver, Left Lobe to New Technology Group 8 with Ultrasound-guided Cavitation, External Approach - XF52X08
• Inspection Hepatobiliary Duct to New Technology Group 7 with Single-use Duodenoscope, Via Natural or Artificial Opening Endoscopic Approach - XFJB8A7
• Inspection Pancreatic Duct to New Technology Group 7 with Single-use Duodenoscope, Via Natural or Artificial Opening Endoscopic Approach - XFJD8A7
• Replacement Skin, Head and Neck to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach - XHR0XGA
• Replacement Skin, Chest to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach - XHR1XGA
• Replacement Skin, Abdomen to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach - XHR2XGA
• Replacement Skin, Back to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach - XHR3XGA
• Replacement Skin, Right Upper Extremity to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach - XHR4XGA
• Replacement Skin, Left Upper Extremity to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach - XHR5XGA
• Replacement Skin, Right Lower Extremity to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach - XHR6XGA
• Replacement Skin, Left Lower Extremity to New Technology Group 10 with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach - XHR7XGA
• Replacement Skin to New Technology Group 7 with Bioengineered Allogeneic Construct, External Approach - XHRPXF7
• Supplement Upper Spine Bursa and Ligament to New Technology Group 8 with Posterior Vertebral Tether, Open Approach - XKUC068
• Supplement Lower Spine Bursa and Ligament to New Technology Group 8 with Posterior Vertebral Tether, Open Approach - XKUD068
• Insertion Pelvic Bone, Right to New Technology Group 8 with Internal Fixation Device with Tulip Connector, Open Approach - XNH6058
• Insertion Pelvic Bone, Right to New Technology Group 8 with Internal Fixation Device with Tulip Connector, Percutaneous Approach - XNH6358
• Insertion Pelvic Bone, Left to New Technology Group 8 with Internal Fixation Device with Tulip Connector, Open Approach - XNH7058
• Insertion Pelvic Bone, Left to New Technology Group 8 with Internal Fixation Device with Tulip Connector, Percutaneous Approach - XNH7358
• Insertion Tibia, Right to New Technology Group 9 with Tibial Extension with Motion Sensors, Open Approach - XNHG0F9
• Insertion Tibia, Left to New Technology Group 9 with Tibial Extension with Motion Sensors, Open Approach - XNHH0F9
• Replacement Skull to New Technology Group 9 with Synthetic Substitute, Ultrasound Penetrable, Open Approach - XNR80D9
• Replacement Tarsal, Right to New Technology Group 9 with Synthetic Substitute, Talar Prosthesis, Open Approach - XNRL099
• Replacement Tarsal, Left to New Technology Group 9 with Synthetic Substitute, Talar Prosthesis, Open Approach - XNRM099
• Reposition Lumbar Vertebra to New Technology Group 2 with Magnetically Controlled Growth Rod(s), Open Approach - XNS0032
• Reposition Lumbar Vertebra to New Technology Group 7 with Posterior (Dynamic) Distraction Device, Open Approach - XNS00C7
• Reposition Lumbar Vertebra to New Technology Group 2 with Magnetically Controlled Growth Rod(s), Percutaneous Approach - XNS0332
• Reposition Lumbar Vertebra to New Technology Group 7 with Posterior (Dynamic) Distraction Device, Percutaneous Approach - XNS03C7
• Reposition Cervical Vertebra to New Technology Group 2 with Magnetically Controlled Growth Rod(s), Open Approach - XNS3032
• Reposition Cervical Vertebra to New Technology Group 2 with Magnetically Controlled Growth Rod(s), Percutaneous Approach - XNS3332
• Reposition Thoracic Vertebra to New Technology Group 2 with Magnetically Controlled Growth Rod(s), Open Approach - XNS4032
• Reposition Thoracic Vertebra to New Technology Group 7 with Posterior (Dynamic) Distraction Device, Open Approach - XNS40C7
• Reposition Thoracic Vertebra to New Technology Group 2 with Magnetically Controlled Growth Rod(s), Percutaneous Approach - XNS4332
• Reposition Thoracic Vertebra to New Technology Group 7 with Posterior (Dynamic) Distraction Device, Percutaneous Approach - XNS43C7
• Supplement Lumbar Vertebra to New Technology Group 6 with Synthetic Substitute, Mechanically Expandable (Paired), Percutaneous Approach - XNU0356
• Supplement Thoracic Vertebra to New Technology Group 6 with Synthetic Substitute, Mechanically Expandable (Paired), Percutaneous Approach - XNU4356
• Fusion Thoracolumbar Vertebral Joint to New Technology Group 10 with Facet Joint Fusion Device, Paired Titanium Cages, Open Approach - XRGA0EA
• Fusion Thoracolumbar Vertebral Joint to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Open Approach - XRGA0R7
• Fusion Thoracolumbar Vertebral Joint to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Percutaneous Approach - XRGA3R7
• Fusion Thoracolumbar Vertebral Joint to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Percutaneous Endoscopic Approach - XRGA4R7
• Fusion Lumbar Vertebral Joint to New Technology Group 10 with Facet Joint Fusion Device, Paired Titanium Cages, Open Approach - XRGB0EA